PCM
AMPH icon

Piermont Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Piermont Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,870
Closed -$204K – 237
2018
Q1 		$204K Sell
10,870
-1,860
-15% -$35K 0.07% 232
2017
Q4 		$245K Sell
12,730
-760
-6% -$14.2K 0.08% 225
2017
Q3 		$241K Sell
13,490
-14,033
-51% -$231K 0.08% 232
2017
Q2 		$492K Sell
27,523
-5,160
-16% -$81.8K 0.14% 228
2017
Q1 		$474K Buy
32,683
+6,530
+25% +$103K 0.11% 235
2016
Q4 		$482K Sell
26,153
-510
-2% -$9.92K 0.11% 228
2016
Q3 		$506K Buy
+26,663
New +$484K 0.12% 235

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return